AML transformation in 56 patients with Ph− MPD in two well defined populationsKhadija Abdulkarim, Björn Andréasson, François Girodon et al.|European Journal Of Haematology|2008Cited by 78
Trends in the incidence of chronic Philadelphia chromosome negative (Ph‐) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983–99Peter Johansson, Börje Ridell, Jack Kutti et al.|Journal of Internal Medicine|2004Cited by 76
The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia veraKhadija Abdulkarim, Björn Andréasson, Börje Ridell et al.|European Journal Of Haematology|2010Cited by 69
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced‐intensity conditioning regimensMats Merup, Vladimir Lazarević, Hareth Nahi et al.|British Journal of Haematology|2006Cited by 56
Increased risk for vascular complications in PRV‐1 positive patients with essential thrombocythaemiaPeter Johansson, Björn Andréasson, Anne Ricksten et al.|British Journal of Haematology|2003Cited by 30